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Abstract
B-1 cells can be differentiated from B-2 cells because they are predominantly located in the
peritoneal and pleural cavities and have distinct phenotypic patterns and activation proper-
ties. A mononuclear phagocyte derived from B-1 cells (B-1CDP) has been described. As
the B-1CDP cells migrate to inflammatory/infectious sites and exhibit phagocytic capacity,
the microbicidal ability of these cells was investigated using the Leishmania major infection
model in vitro. The data obtained in this study demonstrate that B-1CDP cells are more sus-
ceptible to infection than peritoneal macrophages, since B-1CDP cells have a higher num-
ber of intracellular amastigotes forms and consequently release a larger number of
promastigotes. Exacerbated infection by L.major required lipid bodies/PGE2 and IL-10 by
B-1CDP cells. Both infection and the production of IL-10 were decreased when PGE2 pro-
duction was blocked by NSAIDs. The involvement of IL-10 in this mechanism was con-
firmed, since B-1CDP cells from IL-10 KOmice are more competent to control L.major
infection than cells from wild type mice. These findings further characterize the B-1CDP
cells as an important mononuclear phagocyte that plays a previously unrecognized role in
host responses to L.major infection, most likely via PGE2-driven production of IL-10.
Introduction
Macrophages represent distinct cells with phagocytic activity distributed through all tissues.
Originally tissue-resident macrophages were assumed to be derived from circulating mono-
cytes [1] differentiated from bone marrow progenitors. Recently, a change in this dogma was
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provided with conclusive evidences for the existence of a monocyte-independent differentia-
tion pathway of resident macrophages, leading to shift in the paradigm of this model [2,3].
Recently, other studies have suggested that other cell lines could originate phagocytic mac-
rophages [4,5]. These studies are based on previous experiments that demonstrated that B-1
cells present in mice and humans could differentiate into cells with characteristics similar to
macrophages. Borrello and Phipps demonstrated that B-1 cells from the peritoneal cavity of
mice differentiate into a phagocytic cell similar to macrophage-like cells [6]. Differentiation de-
creases immunoglobulin M expression but the expression of rearranged VH11 or VH12, heavy
chain genes persist [7]. Graf et al demonstrated that B/macrophage cells express COX-1, and
up-regulate COX-2 expression and prostaglandin E2 production in response to pro-
inflammatory signals [8].
Several studies investigated the origin [9–12], immunological properties [9,13–18] and the
involvement these cells in inflammatory reactions [15,19–28]. Despite the great interest on this
cell type, little is known about B-1 cells and mainly on B-1 cell derived phagocytes (B-1CDP)
in models of infections by microorganisms [7,21,29,30].
L.major is a protozoan parasite transmitted by sandflies of the genus Lutzomyia that inject
the promastigote form into the dermis of the host. Once injected, the parasite is rapidly en-
closed by phagocytic cells and transforms into the replicative intracellular amastigote form
[31]. In susceptible hosts, such as BALB/c mice, L.major elicits a Th2 immune response and in-
duces a progressive infection. In susceptible hosts, macrophages produce anti-inflammatory
factors, such IL-10, TGF-β and PGE2, which act in favor of the protozoan [32].
Based on these data, we decided to investigate the interaction of B-1CDP cells from BALB/c




This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health (USA). The protocol
was approved by the Committee on the Ethics of Animal Experiments of the Health Science
Center of the Federal University of Rio de Janeiro (CEUA-CCS, Permit Number: IMPPG 038-
05/16) and all efforts were made to minimize suffering.
Mice and parasite
BALB/c mice of both sexes, aging 6–8 wk, were from Oswaldo Cruz Institute Animal Care Fa-
cility (Fiocruz, Rio de Janeiro, Brazil) C57BL/6 IL-10 Knock-out (KO) and C57BL/6 wild-type
mice were kindly donated by Professor João Santana Silva from the Department of Pharmacol-
ogy, School of Medicine, USP, Ribeirão Preto. L.major strain LV39 (MRHO/Sv/59/P) was iso-
lated monthly from footpads of infected BALB/c mice and maintained in vitro as proliferating
promastigotes. Parasites were maintained in Schneider medium (Life Technologies) supple-
mented with 10% FCS, 1% glutamine and 2% human urine.
Cell culture
B-1CDP cells obtained as previously described [33]. Briefly, resident peritoneal cells were col-
lected from peritoneal washouts of BALB/c mice. Cells (2 X 106) were dispensed on 10 cm di-
ameter plastic plates and the cultures incubated ay 37°C in 7% CO2 for 1h. After incubation,
the culture supernatants were aspirated to remove non-adherent cells. Adherent monolayers
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were rinsed with antibiotic-free RPMI-1640 medium (Sigma), contained 15 mMHEPES, 2g of
sodium bicarbonate/liter, 1mM L-glutamine and kept in 0,5 ml of antibiotic-free RPMI medi-
um plus 10% fetal bovine serum for 6 days. B1 cells present in the supernatant of these cultures
were aspirated, centrifuged, re-suspended in RPMI medium plus 1 0% fetal bovine serum and
dispensed on cover slips in the bottom of 6 well plates. After 3 days in culture B-1CDP, adher-
ent to the glass surface were removed from the substrate by ice-cold phosphate-buffered saline.
Cells were counted, added (2 X 105) to glass cover slips inserted in 24-well tissue culture plates.
Peritoneal macrophages cultures were made as above described using adherent cells from the
peritoneal cavity of BALB/c. Peritoneal macrophages were counted, added (2 X 105) to glass
cover slips inserted in 24-well tissue culture plates.
Infection
B-1CDP cells and peritoneal macrophages were plated in 24 wells tissue culture plates (Nunc,
Roskilde, Denmark) at 2 X 105 cells/well in RPMI medium plus 10% fetal bovine serum. Cells
immediately received 1X106 stationary phase L.major promastigote, and were incubated in
medium 10% FCS at 37°C. After 4 hours, monolayers were extensively washed with warm
HBSS, to remove extracellular parasites. All cultures were done in medium 1% Nutridoma-SP,
instead of FCS.
Antibodies, cytokines and inhibitors
B-1CDP cells or peritoneal macrophage monolayers were treated with 1 μg/mL indomethacin,
10 μg/mL Aspirin (Sigma-Aldrich) or 1 μM/mL NS-398 (CaymanChem), or equivalent dosage
of solvent (DMSO). Neutralizing anti-TGF-β and normal chicken IgY (R&D System), anti-IL-
10 and rat IgG1 isotype control (BioSource Europe, Nivelles), were used at 10 μg/mL.
Assessment of intracellular load of L.major
After 3 days, infected B-1CDP cells and macrophages monolayers were extensively washed,
and medium was replaced by 0,5 ml of Schneider medium (Life Technologies), supplemented
with 20% FCS and 2% human urine [34]. Monolayers were cultured at 26°C for additional
3 days. Intracellular load of L.major amastigote was estimated by production of proliferating
extracellular motile promastigote in Schneider medium [34]. Alternatively, infected B-1CDP
cells and peritoneal macrophages were cultured on glass coveslips place inside culture vessels
(Corning) at 37°C in 7% CO2. After 4 days, coverslips were washed and stained with May-
Grunwald Giemsa (Sigma-Aldrich), and intracellular amastigotes were counted in 100 B-
1CDP cells or macrophages. Results are shown as amastigote number per phagocyte, and as
percentage of infected macrophages. All results are mean and SE of triplicated cultures.
Lactate Dehydrogenase Assay
In order to evaluate the integrity infected B-1CDP cells and peritoneal macrophages, an aliquot
of the supernatant was withdrawn and frozen for determination of LDH release. LDH activity
was evaluated by using an assay kit (Doles Reagents, Brazil), which measure the amount of a
colored complex derived from the NADH formed by the enzymatic reaction, using a spectro-
photometric method (A490).
Immunofluorescence Microscopy
Infected B-1CDP cells and macrophages were obtained as described above. After different time
in culture, cells were fixed for 1 h in 3.5% formalin. After fixation, cells were washed in PBS
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containing 1% BSA (Sigma) to block free sites and permeabilized by treatment with 0.05% sa-
ponin (Sigma) for 30 min. Polyclonal goat antibody anti-mouse IgM-FITC (μ chain specific)
(Sigma) (1:1000) and biotin rat antibody anti-mouse F4/80 was diluted in PBS/BSA/saponin
and incubated for 1 h at room temperature. After three washes in the same solution, glass
cover slips were incubated with anti-rat IgG-FITC (F4/80). After incubation, glass cover slips
were washed again and incubated in 1 μg /mL of DAPI. After 10 min of incubation, glass cover
slips were washed, mounted in 0.1 M glycerol and sealed with nail varnish. Images were ac-
quired using a Zeiss Observer Z.1 microscope in a 63x objectives. The images were processed
with a deconvolution module using Zen software.
Determination of mediators
The concentrations of cytokines in the supernatant obtained from cultures of infected B-1CDP
cells or peritoneal macrophages were quantified after 24 hours of incubation by the method of
sandwich immunoassay (ELISA) according to methodology recommended by the manufactur-
er (R&D). The optical density was obtained by reading in a plate spectrophotometer (Versamax
Microplates Reader Molecular Devices, USA), with filter of 405 nm. The concentrations of cy-
tokines were calculated from a standard curve of recombinant cytokines. Quantification of
PGE2 was obtained by a PGE2 specific EIA kit, according to methodology recommended by the
manufacturer (Cayman Chemical, Ann Arbor, MZ).
Lipid bodies
To observe LBs, B-1CDP cells and macrophages were first fixed in 3,5% formalin in PBS for
30 min at room temperature, then stained with Nile red (Sigma) for 10 minutes (RT) at a final
concentration of 10 mg/ml [35]. Following brief washes with PBS, and the slides were, stained
with DAPI (Sigma). The morphology of fixed cells was observed, and Nile Red LBs were
counted by light microscopy with a 100X objective lens in 50 consecutively scanned leukocytes.
Statistical analysis
Statistical analysis was performed in the program GraphPad InStat version 3.01 (San Diego,
USA). Data were analyzed by the method of Student’t test. Differences with a p value 0.05 or
lower were considered significant.
Results
B-1CDP cells are more susceptible to infection with L.major in
comparison with peritoneal macrophages
Macrophages correspond to the main reservoir of Leishmania infection in vivo. We evaluated
the susceptibility/resistance to L.major infection of B-1CDP cells in comparison with
peritoneal macrophages.
B-1CDP cells and peritoneal macrophages were infected with L.major promastigotes and
amastigotes were counted. Our results demonstrated that B-1CDP cells exhibit a greater num-
ber of intracellular amastigotes when compared with peritoneal macrophages (Fig 1A and
S1 Fig) and were more permissive to infection, since they showed a higher percentage of in-
fected cells (Fig 1B).
Furthermore, after 5 days of culture we observed a greater release of motile promastigotes
forms of L.major in the supernatant of infected B-1CDP cells when compared to promastigotes
present in the supernatant of peritoneal macrophages (Fig 1C). Despite of these differences, the
parasite burden at 4 hours post-infection was identical for both cell types (S2 Fig).
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Fig 1. B-1CDP cells exhibit a susceptible phenotype to infection with L.major in vitrowhen compared
to peritoneal macrophages. B-1CDP cells and peritoneal macrophages were cultured (105/ml) and infected
with metacyclic promastigotes of L.major. After 24 hours, the cell culture was washed and phagocytes were
cultured for another 3 days with DMEM supplemented with 10% FBS at 37°C. After this period, cells were
stained and amastigotes inside the phagocytes were counted under the light microscope (A) and set the
percentage of infected cells (B). To quantify promastigotes forms in the supernatants, the cells were infected
with L.major. After 24 hours of infection, cells were washed and cultured in Schneider medium for 5 days at a
PGE2/IL-10 Facilitates Infection of L. major in B-1CDP Cells
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Detection of IL-10 in culture supernatants from infected B-1CDP cells
controls L.major growth
It is known that B-1 cells produce IL-10 and use this cytokine as an autocrine growth factor
[36]. Also this cytokine is an important regulator of macrophages [37]. Since B-1CDP cells are
potent sources of IL-10, we decided to investigate whether IL-10 could be involved in infectivity
of B-1CDP cells to L.major in vitro.
The results shown in Fig 2A confirm that B-1CDP cells produce more IL-10 than peritoneal
macrophages. We also evaluated the production of TGF-β, which is another important immu-
noregulatory factor produced by phagocytes [38–40]. However, our results did not show a re-
markable production of TGF-β by B-1CDP cells (data not shown).
Next we evaluated the possible immunomodulatory role of IL-10 in the infection of B-
1CDP cells in comparison with peritoneal macrophages. Our results showed that the use of a
neutralizing anti-IL-10 antibody induced a remarkable reduction in parasitic load both in peri-
toneal macrophages and B-1CDP cells (Fig 2B). It is important to emphasize that the negative
modulation induced by neutralization of IL-10 was more pronounced in cultures of infected
B-1CDP cells. This result strongly suggests that there is indeed a close relationship between the
susceptibility of B-1CDP cells to infection by L.major and the increased production of the cy-
tokine IL-10.
B-1CDP cells produce high amounts of lipid bodies
Lipid bodies are organelles consisting of a core of rich neutral lipids and wrapped with a mono-
layer of phospholipids, cholesterol, lipids, which contain a variety of proteins associated with
different functions in cell metabolism, signaling, and inflammation [41]. Several groups have
reported that host cells have their lipid metabolism altered and increase their number of lipid
bodies following infection with intracellular pathogens [42–46]. Furthermore, our group has
shown an increase of lipid bodies in macrophages infected with Trypanosoma cruzi, and their
role in disease development [40].
Based on this information, we investigated the presence of cytoplasmic lipid body organelles
in B-1CDP cells and compared their number to peritoneal macrophages. We also investigated
the generation of these organelles when peritoneal macrophages or B-1CDP cells were infected
with L.major. Our data demonstrate that B-1CDP cells express a large number of lipid bodies
in the cytoplasm even in the absence of stimulus (Fig 3A). After 24 hours of infection, we
found that B-1CDP cells had a larger amount of lipid bodies compared to peritoneal macro-
phages (Fig 3B). However, infection per se did not increase statistically the number of lipid
bodies in B-1CDP cells (Fig 3C).
B-1CDP cells secrete high levels of PGE2
Lipid bodies are cellular sites devoted to the synthesis of PGE2 [40]. Previous studies reported
that Leishmania infection induces PGE2 production and that this production could favor the
persistence and/or progression of disease [47]. Furthermore, B-1CDP cells constitutively ex-
press COX-1 and COX-2 enzymes, and produce considerable quantities of PGE2 in response to
inflammatory signals [8]. Based on these data, we evaluated the involvement of lipid mediator
PGE2 in infection of B-1CDP cells with L.major. For this purpose, we measured this lipid
temperature of 27°C. After this period, the promastigotes were quantified in the supernatant of the cultures of
infected phagocytes (C). All cultures were performed in triplicate and bars show the mean + SD. Statistical
analysis were performed by T-Test from representative results of three similar experiments. **p 0.05.
doi:10.1371/journal.pone.0124888.g001
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mediator in the culture supernatant after 24 hours of infection. As demonstrated in Fig 4,
B-1CDP cells produce considerable amounts of PGE2 even in the absence of stimulus, and in-
fection did not changing it significantly.
In order to determine whether PGE2 synthesis regulates parasite load, we used three differ-
ent non-steroidal anti-inflammatory drugs (NSAIDs): Aspirin (Fig 5A), indomethacin (Fig 5B)
and NS-398 (Fig 5C). The three drugs act as inhibitors of PGE2 production [38,48]. Our results
demonstrate that inhibition of PGE2 production was accompanied by diminished parasite bur-
den. It is important to emphasize that the inhibition was more pronounced in cultures of
Fig 2. IL-10 is determinant for the increased parasite load in B-1CDP. B-1CDP cells and peritoneal macrophages were cultured in the presence or
absence of L.major (MOI 10:1). After 24 hours, the supernatant was collected and IL-10 (A) was measured by ELISA. All cultures were performed in triplicate
and bars show the mean ± SD. Representative result of three similar experiments **p <0.05. B-1CDP cells and peritoneal macrophages were treated or not
with doses of monoclonal neutralizing anti-IL-10 or control isotype. Once were infected with L.major, after 24 hours, the cell cultures were washed with
DMEM and incubated 3 days and then passed to Schneider medium. After 5 days in medium Schneider, promastigotes were counted in the supernatant (B).
Statistical analysis were performed by Student’ t test from representative results of three similar experiments and bars show the mean +SD. **p 0.05.
doi:10.1371/journal.pone.0124888.g002
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B-1CDP phagocytes treated with inhibitors (Fig 5A–5C). Treatment with NSAIDs drugs were
not toxic to phagocytes, as measured by LDH release (S3 Fig).
Effect of aspirin on IL-10 production and parasite release
After verifying the effect of cyclooxygenase inhibition on the parasite load, we investigated an
effect on the production of IL-10 by B-1CDP. Our data demonstrate a significant decrease in
the levels of IL-10 in the supernatant when we used NSAIDs in our system (Fig 6).
Fig 3. B-1CDP cells naturally express increased numbers of lipid bodies as compared to peritoneal macrophages. B-1CDP cells (A) and peritoneal
macrophages (B) were incubated with glass coverslips, some cultures were infected with L.major (3C). Stained with Nile red (Sigma), the slides were
washed and stained with DAPI (Sigma). The morphology of fixed cells was observed, and Nile red LBs were counted by light microscopy with a 100×
objective lens in 50 consecutively scanned leukocytes. Statistical analysis were performed by Student’ t test from representative results of three similar
experiments and bars show the mean +SD. **p 0.05. Bar, 10 μm. Representative of two experiments with identical results.
doi:10.1371/journal.pone.0124888.g003
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B-1CDP cells from IL-10 KOmice are more competent to control
L.major infection
To confirm that the production of IL-10 is involved in the susceptibility to infection by
L.major, we used B-1CDP cells from IL-10 KO mice. When compared to B-1CDP from wild
type mice, the cells from IL-10 KOmice were more resistant to infection. Our data demonstrat-
ed a decrease in the number of intracellular amastigotes (Fig 7A) and percentage of infected
cells (Fig 7B). Also, we observed the significant decrease in the amount of promastigote forms
released by B-1CDP cells from IL-10 KO mice (Fig 7C). However, we did not observe any dif-
ferences in parasitic capture by B-1CDP cells 4 hours after infection (data not shown).
Discussion
Phagocytosis is predominantly performed by professional phagocytes, such as polymorphonu-
clear cells, monocytes and macrophages [49]. Other types of cells such as fibroblasts and epi-
thelial cells are also capable of phagocytizing particles, but in a much smaller degree compared
to professional phagocytes.
Unlike professional phagocytes, most B cell subpopulations cannot perform phagocytosis
[50]. However, several studies have discussed the mechanisms by which B-1 cells differentiate
into phagocytes and the ontogenetic and physiological implications of this phenomenon. Re-
ports in the literature have shown that pre-CD5+ B cells can differentiate into cells similar to
macrophages [43,51].
Moreover, a link between the development of B-1 cells and macrophages was established by
identifying bi-phenotypic B cell/macrophage progenitors in fetal liver [17] and adult bone mar-
row [51]. The presence of bi-phenotypic B cell/macrophage precursor in mammals suggests a
close evolutionary relationship between B cells and macrophages derived from monocytes,
which indicates the possibility of a common phylogenetic ancestor with attributes of both cell
types, which has already been demonstrated in teleost fish [52].
Fig 4. B-1CDP cells secrete high levels of PGE2 regardless the infection. B-1CDP cells and
macrophages were incubated in the presence or absence of L.major (MOI 10:1). After 24 hours of infection
the supernatant was collected, and PGE2 was measured by EIA. All cultures were performed in triplicate and
bars show the mean ± SD. Statistical analysis were performed by Student’ t test from representative results of
three similar experiments and bars show the mean +SD. **p 0.05.
doi:10.1371/journal.pone.0124888.g004
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Fig 5. Blockage of the cyclooxygenase pathway shift the B-1CDP cells to protective phenotype in the Lmajor infection.Macrophages and B-1CDP
were incubated in the presence or absence of L.major treated or not with (A) aspirin (10 mg/mL), (B) indomethacin (1 mg/mL) or (C) NS-398 (1 mM). After
24 hours of incubation the cells were washed and incubated again for 5 days. After this time, the promastigotes were counted in the culture supernatant. All
cultures were performed in triplicate and bars show the mean ± SD. Statistical analysis were performed by Student’ t test from representative results of three
similar experiments and bars show the mean +SD. **p 0.05.
doi:10.1371/journal.pone.0124888.g005
PGE2/IL-10 Facilitates Infection of L. major in B-1CDP Cells
PLOS ONE | DOI:10.1371/journal.pone.0124888 May 1, 2015 10 / 18
Borrello and Phipps [6] demonstrated the differentiation of splenocytes simultaneously ex-
pressing B-cell and macrophage characteristics, when co-cultured with fibroblasts. Almeida
and colleagues [33] showed that peritoneal B-1 cells proliferate and differentiate into new
mononuclear phagocytic cells with no relation to blood derived monocytes. A further evidence
for this B-1 cell/phagocyte link are discussed elsewhere [4].
In the present study, we demonstrate that phagocytes derived from B-1 cells (called B-
1CDP) have the ability to phagocytose the pathogenic protozoan parasite L.major. Moreover,
B-1CDP cells are more susceptible to infection with this parasite when compared with murine
peritoneal macrophages; the intracellular load of amastigote can also be indirectly evaluated by
the ability of host cells to release promastigotes following culture in Schneider medium [34].
The amount of released promastigotes in the supernatants after 5 days of infection was higher
in cultures of the B-1CDP cells, as compared to cultures of murine peritoneal macrophages.
We investigated which cytokines could be involved in this phenomenon. The cytokine IL-10 is
produced by different cell types, such as macrophages, dendritic cells (DC), B cells and differ-
ent subtypes of T lymphocytes [53,54]. Many of the effects of IL-10 on the functions of T cells
and NK cells are now known to be mediated by a direct effect of IL -10 on macrophages. In ad-
dition, IL-10 may act directly on CD4+ T cells by inhibiting the production and proliferation
of IL-2, IFN-γ, IL-4, IL-5 and TNF-α [53,55,56]. It is well characterized that IL-10 plays an im-
portant role in susceptibility to leishmaniasis. It suppresses the synthesis of the inflammatory
cytokine IFN-γ and can inhibit the production of NO by activated macrophages and also
down-regulates the expression of MHC class I and class II and co-stimulatory molecules (B7.1
and B7.2) on the surface of macrophages [57]. Furthermore, BALB/c mice deficient in IL-10
could control the L.major infection, suggesting that this cytokine might play an important role
in mediating susceptibility to and pathogenesis of experimental cutaneous leishmaniasis [58].
The TGF-β is an important cytokine with anti-inflammatory activity, which was character-
ized as an important factor related susceptibility to experimental infection by Leishmania in
vivo [59]. Our results indicated that the susceptibility to L.major infection presented by B-
1CDP cells is related to the production of IL-10. Surprisingly, our results also indicated that the
cytokine TGF-β is not involved in the increased infection of B-1CDP cells (data not shown).
Fig 6. Effect of inhibition of PGE2 on IL-10 releases.Macrophages and B-1CDP cells were incubated with or without aspirin (10μg/mL) for 1 hour. They
were then incubated in the presence or absence of L.major (MOI 10:1). After 24 hours of incubation, the supernatant was collected and IL-10 measured by
ELISA. All cultures were performed in triplicate and bars show the mean ± SD. Statistical analysis were performed by Student’ t test from representative
results of three similar experiments and bars show the mean +SD. **p 0.05.
doi:10.1371/journal.pone.0124888.g006
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Fig 7. B-1CDP cells from IL-10 deficient mice are more competent to control L.major infection. To
confirm the production of IL-10 is involved in the susceptibility to infection by L.major, we used B-1CDP cells
from IL-10 KOmice. When compared to B-1CDP from wild type mice, the cells from IL-10 KOmice are more
resistant to infection. Our data demonstrate decreased in the number of intracellular amastigotes (A) and
percentage of infected cells (B). We also observed the significant decrease in the liberated promastigotes
forms by B-1CDP from IL-10 KOmice (C). Statistical analysis were performed by Student’ t test from
representative results of three similar experiments and bars show the mean +SD. **p 0.05.
doi:10.1371/journal.pone.0124888.g007
PGE2/IL-10 Facilitates Infection of L. major in B-1CDP Cells
PLOS ONE | DOI:10.1371/journal.pone.0124888 May 1, 2015 12 / 18
B-1CDP cells produce a large quantity of IL-10 even without stimulation, in agreement with
a marked anti-inflammatory profile [13,21], and with a propensity for infection by Leishmania.
The role of IL-10 was confirmed by showing that a neutralizing antibody specific for IL-10 in-
duced significant reduction in the amount of promastigotes released in culture supernatants.
Another aspect that could lead to increased susceptibility of B-1CDP cells to L.major infec-
tion, were the lipid bodies presented in that cell population. Lipid bodies are key organelles in-
volved in cholesterol metabolism and the synthesis of fatty acids indicating that both anabolic
and catabolic phases of lipid metabolism occur in these organelles [60,61]. Leukocytes have few
lipid bodies, but these cells can be stimulated to form new lipid bodies quickly [62]. Accumula-
tion of lipid bodies was also identified within peritoneal macrophages during the acute phase
of experimental infection with the parasite T. cruzi and L. amazonensis [40,63]. Consistent
with the role of inflammation on the leucocytes, the lipid bodies formed by these cells are im-
portant sites for the production of inflammatory mediators. Lipid bodies contain arachidonic
acid, which serves as a precursor for the synthesis of eicosanoids, and all the enzymes necessary
for this synthesis, including cyclooxygenase (COX), PGE2 synthase, 5/15-lipoxygenase (5-LO
and 15-LO), and leukotriene C4 synthase [64].
As demonstrated in our study, the B-1CDP cells contain a large amount of cytoplasmatic
lipid bodies compared with murine peritoneal macrophages. As the increased numbers of cyto-
plasmatic lipid bodies is associated to increase PGE2 production, the result on the L.major in-
fection was expected. Our data shows that the inhibition of the PGE2 modulated the infection
causing the decreased release of promastigotes forms by B-1CDP cells. PGE2 is known to be an
important inducer of cytokines as TGF-β [38,48] and IL-10 [65].
The formation of lipid bodies within inflammatory macrophages positively correlates with
increased generation of PGE2, indicating a role for these organelles in enhanced production of
eicosanoids observed in Chagas´ disease [66]. The increased capacity of macrophages to gener-
ate PGE2 in the course of a pathogenic infection due to the increased formation of lipid bodies
may contribute to mechanism by which intracellular pathogens survive in the host cells. The
high concentration of PGE2 is a potent inhibitor of the T cell response and NO production by
macrophages, favoring the growth of the intracellular parasite [38,39,67]. In addition, PGE2 is
essential for the increased growth of parasites in macrophages that have ingested of apoptotic
cells [38,48].
IL-10 produced by B-1CDP cells is the key to understanding their increased susceptibility to
infection. Using B-1CDP cells from IL-10 KO mice the infection with L.major was less effec-
tive. These results strongly suggest that IL-10 secreted by B-1CDP cells, and probably B-1 cells
as well, are involved in the susceptibility to infection. Popi and colleagues [68], using the Cox-
iella burnetti cell infection model in vitro, obtained a similar result. They found that peritoneal
macrophages from BALB/c XID mice, which are deficient in B-1 cells, mice are more resistant
to intracellular infection by C. burnetti when compared with peritoneal macrophages from
wild-type BALB/c mice. The involvement of B-1 cells in experimental infection with Leishman-
ia remains unclear, only two independent studies have reported the involvement of these cells
in the infection, however the results were not conclusive [69,70].
Altogether, our data unveil that PGE2-driven production of IL-10 determines susceptibility
of B-1CDP cells to L.major infection. Little is known about the physiology of B-1CDP cells,
and their immune functions. The implications of our present findings in the pathophysiology
of immunity remain open for further investigation. The “promiscuous" expression of both my-
eloid and lymphoid characteristics of a single cell type, and the factors governing differentia-
tion of B-1 cells in B-1CDP cells will certainly open new avenues for the understanding of
lymphoid and myeloid cells and their role in parasitic diseases.
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Supporting Information
S1 Fig. B-1CDP cells exhibit a significant number of intracellular amastigotes compared
with macrophages peritoneal. B-1CDP cells (A) and peritoneal macrophages (B) were cul-
tured (105/ml) and infected with promastigotes of L.major. After 24 hours, the cell culture was
washed and phagocytes were cultured for another 3 days with DMEM supplemented with 10%
FBS at 37°C. After this period, cells were fixed and permeabilized. Following incubation with
Polyclonal goat antibody anti-mouse IgM-FITC (B-1CDP cells) and rat anti-mouse F4/
80-FITC (macrophages). After incubation, glass cover slips were washed again and incubated
in 1 microgram/mL of DAPI. After 10 min of incubation, glass cover slips were washed and
mounted. Images were acquired using a Zeiss Observer Z.1 microscope in a 63x objectives.
After the acquisition, images were processed with a deconvolution module using Zen software.
Bar, 10 μm. Representative of two experiments with identical results.
(TIF)
S2 Fig. Comparison of the susceptibility to L.major infection between B-1CDP cells and
peritoneal macrophage. B-1CDP cells and peritoneal macrophages were cultured (105/ml)
and infected with metacyclic promastigotes of L.major. After 4 hours, the cell culture was
washed and cells were stained and parasites inside the phagocytes were counted under the light
microscope. All cultures were performed in triplicate and bars show the mean +SD.
(TIF)
S3 Fig. Lactate dehydrogenase assay of infected B-1CDP cells and peritoneal macrophages
in the presence of NSAIDs. B-1CDP cells and peritoneal macrophages were cultured (105/ml)
and infected with promastigotes of L.major were treated or not with aspirin (10 mg/mL), indo-
methacin (1 mg/mL) or NS-398 (1 mM). After 72 hours of incubation the supernatant was
withdrawn and frozen for determination of LDH release.
(TIF)
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